M. E. Yildirim Et Al. , "Real-world treatment outcomes from nationwide Onco-colon Turkey registry in RAS wild-type patients treated with biologics second-line mCRC.," JOURNAL OF CLINICAL ONCOLOGY , vol.40, no.16, 2022
Yildirim, M. E. Et Al. 2022. Real-world treatment outcomes from nationwide Onco-colon Turkey registry in RAS wild-type patients treated with biologics second-line mCRC.. JOURNAL OF CLINICAL ONCOLOGY , vol.40, no.16 .
Yildirim, M. E., Karaca, M., Artac, M., Cicin, I., Geredeli, C., Alacacioglu, A., ... Simsek, E. T.(2022). Real-world treatment outcomes from nationwide Onco-colon Turkey registry in RAS wild-type patients treated with biologics second-line mCRC.. JOURNAL OF CLINICAL ONCOLOGY , vol.40, no.16.
Yildirim, Mahmut Et Al. "Real-world treatment outcomes from nationwide Onco-colon Turkey registry in RAS wild-type patients treated with biologics second-line mCRC.," JOURNAL OF CLINICAL ONCOLOGY , vol.40, no.16, 2022
Yildirim, Mahmut E. Et Al. "Real-world treatment outcomes from nationwide Onco-colon Turkey registry in RAS wild-type patients treated with biologics second-line mCRC.." JOURNAL OF CLINICAL ONCOLOGY , vol.40, no.16, 2022
Yildirim, M. E. Et Al. (2022) . "Real-world treatment outcomes from nationwide Onco-colon Turkey registry in RAS wild-type patients treated with biologics second-line mCRC.." JOURNAL OF CLINICAL ONCOLOGY , vol.40, no.16.
@article{article, author={Mahmut Emre Yildirim Et Al. }, title={Real-world treatment outcomes from nationwide Onco-colon Turkey registry in RAS wild-type patients treated with biologics second-line mCRC.}, journal={JOURNAL OF CLINICAL ONCOLOGY}, year=2022}